| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/06/2008 | CN101234153A Externally-applied medicament for treating bone fracture |
| 08/06/2008 | CN101234152A Method for manufacturing quick-effective bone setting powder |
| 08/06/2008 | CN101234149A Composition for treating pain of head, face and limbs and various tendons clonic convulsion and preparation thereof |
| 08/06/2008 | CN101234143A Method for preparing plaster for treating lumbar sprain disease |
| 08/06/2008 | CN101234137A Drug for curing coronary disease |
| 08/06/2008 | CN101234135A Chinese medicine for curing cough |
| 08/06/2008 | CN101234128A Paederus extraction liquid and preparation and application thereof |
| 08/06/2008 | CN101234127A Technique for extracting natural antibacterial agent from low value sea water fish and leftover protein |
| 08/06/2008 | CN101234126A Collagen peptide of Jellyfish with anti-fatigue active and preparation technique thereof |
| 08/06/2008 | CN101234078A Preparation technique of blood streptococcus signal molecule micro-ecological preparations and oral health products thereof |
| 08/06/2008 | CN101233838A Method for inducing spider to generate antibiotic activity substance |
| 08/06/2008 | CN101233836A High-efficiency organic circulating agricultural production system |
| 08/06/2008 | CN100408682C MUC-1 antigen with reduced number of VNTR repeat units |
| 08/06/2008 | CN100408592C Fractionation of phytosterol esters in oil |
| 08/06/2008 | CN100408108C New product |
| 08/06/2008 | CN100408098C Application polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of tumor and diabetes mellitus |
| 08/06/2008 | CN100408092C Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 08/06/2008 | CN100408088C Medicine for treating oral ulcer |
| 08/06/2008 | CN100408087C Medicine for treating bronchial asthma |
| 08/06/2008 | CN100408084C Tujia nationality proved medicine recipe for treating cancer and tumour, and its preparation method |
| 08/06/2008 | CN100408083C Chinese medicinal composition for treating calculus |
| 08/06/2008 | CN100408081C Anti-tumor cancer-diminishing medicine and preparing method |
| 08/06/2008 | CN100408078C Medicinal composition for treating hyperplasia of prostate and its preparing method |
| 08/06/2008 | CN100408077C A Chinese traditional medicinal composition used for treatment of nephritis and uraemia |
| 08/06/2008 | CN100408076C Traditional Chinese medicine oral prepn. for treating psoriasis |
| 08/06/2008 | CN100408074C Chinese traditional medicine for treating diseases of high blood pressure, cerebral arteriosclerosis, cerebral infarction, cerebral thrombosis, cerebral hemorrhage and brain atrophy and preparation me |
| 08/06/2008 | CN100408073C Chinese patented medicine for treating lumber spinal canal stenosis |
| 08/06/2008 | CN100408065C Chinese medicinal preparation for treating stomatocace and preparation method thereof |
| 08/06/2008 | CN100408060C Externally applied medicinal wine for treating rheumatism |
| 08/06/2008 | CN100408059C Heat-clearing effervescence tablet for infants and its preparing method |
| 08/06/2008 | CN100408056C Ointment for treating burn and empyrosis, and its preparing method |
| 08/06/2008 | CN100408055C Chinese medicinal composition for treating traumatic diseases, its preparation method and quality control method |
| 08/05/2008 | US7408039 Induction of chimera mixture; anticancer agents, leukemia |
| 08/05/2008 | US7407936 Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy |
| 08/05/2008 | US7407934 Controlling blood glucose concentration; amylin antagonist such as 25,28,29Pro-h-amylin, pramlintide; reducing gastric motility and delaying gastric emptying |
| 08/05/2008 | US7407805 Keratinocytes and culture medium containing ascorbic and linoleic acid, vitamin e, epidermal growth factor; has surface electrical capacitance of given values |
| 08/05/2008 | US7407751 Methods for the detection and prognosis of breast tumors |
| 08/05/2008 | US7407663 Modified immunodeficiency virus particles |
| 08/05/2008 | US7407661 Methods and reagents that generate a CD8 T cell immune response |
| 08/05/2008 | US7407654 From fermentation of Streptomyces; bactericides |
| 08/05/2008 | CA2367694C Biological fluid filter and system |
| 08/05/2008 | CA2340888C Novel tumor antigen protein sart-3 and tumor antigen peptide thereof |
| 08/05/2008 | CA2331593C Metabolites of ecteinascidin 743 |
| 08/05/2008 | CA2286482C Nkt cell-activating agents containing .alpha.-glycosylceramides |
| 07/31/2008 | WO2008091908A2 Human cancer stem cells |
| 07/31/2008 | WO2008091161A1 Cosmetic composition containing spermine and emu oil |
| 07/31/2008 | WO2008091013A1 Method for preparation of cartilage cell |
| 07/31/2008 | WO2008090826A1 Method for production of mesenchymal cell, method for production of tooth, and mesenchymal cell for formation of tooth |
| 07/31/2008 | WO2008068621A3 Combination product with ido inhibitor and tumor targeted ifn-gamma |
| 07/31/2008 | WO2008067651B1 Gender selection with the use of antibodies |
| 07/31/2008 | WO2008057580A3 Materials and methods for treating and managing angiogenesis-mediated diseases |
| 07/31/2008 | WO2007141657B1 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation |
| 07/31/2008 | WO2007118077A3 Mycobacterial catalase-peroxidase in the diagnosis and treatment of sarcoidosis |
| 07/31/2008 | WO2006104609A3 Isolated myeloid-like bone marrow cell populations and methods of treatment therewith |
| 07/31/2008 | US20080182981 Method and medicament for inhibiting the expression of a given gene |
| 07/31/2008 | US20080182807 gene therapy against tumors and cancer; expression vector includes insert into tumor an effective amount of polynucleotides encoding a functionally active p53, express p53 to first DNA damaging agent, contact tumor cell with first DNA damaging agent, and kill tumor cell |
| 07/31/2008 | US20080182803 extract from Cassia or Senna plants comprises rubrofusarin gentiobioside with egg white, egg membrane, milk whey, yeast/vegetable proteins, soy bean, L-cysteine, L-methionine, and vitamin C; synergistic; intracellular biosynthesis of glutathione stimulator; liver, brain, vision, or immune disorders |
| 07/31/2008 | US20080182329 Methods and products related to metabolic interactions in disease |
| 07/31/2008 | US20080182320 Two-step immunization procedure against chlamydia infection |
| 07/31/2008 | US20080182314 Neuronal serine threonine protein kinase |
| 07/31/2008 | US20080182313 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening |
| 07/31/2008 | US20080181967 including solutions, gels, and pastes, manufactured from placental tissue or umbilical cord tissue components soluble in aqueous solution, and substantially lacking placental tissue components or umbilical cord components insoluble in aqueous solution at neutral pH; vision defect; |
| 07/31/2008 | US20080181954 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas |
| 07/31/2008 | US20080181935 Base-treated, detergent-treated telopeptide collagen and a plurality of stem cells; kit for augmenting, bulking or replacing tissue of a mammal |
| 07/31/2008 | US20080181924 Culture and Use of Cells That Secrete Liver Secretory Factors |
| 07/31/2008 | US20080181901 Protein modulator of the plasma membrane Na,K-ATPase |
| 07/31/2008 | US20080181873 produce more stem cells in vivo or in vitro by culture, for transplantation into patient; increase neurogenesis or new olfactory neuron numbers; stroke, neurodegenerative disease of Alzheimer's disease, multiple sclerosis, Huntington's disease, amyotrophic lateral sclerosis, and Parkinson's disease |
| 07/31/2008 | US20080181871 Focal calcium channel modulation |
| 07/31/2008 | US20080181870 brain cancer treatment with a mixture of a viral vector and ganciclovir; delivered to target cells; provide prolong survival |
| 07/31/2008 | US20080181869 antiproliferative, antiinflammatory agent; cytokine suppressive pro- or anti-inflammatory drug; decrease in fibroblast activation, decrease in fibroblast differentiation, decrease in collagen synthesis and deposition, or increase in matrix metalloproteinase (MMP) expression or activity |
| 07/31/2008 | US20080181864 Reducing mitochondrial membrane potential in mammalian cell by administering an major histocompatibility complex (MHC) class II HLA-DR (human leukocyte antigen) ligand; control disease by manipulating mitochondrial metabolism; drug screening antitumor drug; treating human breast cancer |
| 07/31/2008 | US20080181849 Methods, kits and compositions comprising crotamine |
| 07/31/2008 | CA2676174A1 Method for production of mesenchymal cell, method for production of tooth, and mesenchymal cell for formation of tooth |
| 07/31/2008 | CA2675521A1 Human cancer stem cells |
| 07/30/2008 | EP1950307A1 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein |
| 07/30/2008 | EP1949909A1 Use of Botulinum Toxin Therapy for Treatment of Urge Type Dysfunction |
| 07/30/2008 | EP1949905A1 Reovirus for the treatment of cellular proliferative disorders |
| 07/30/2008 | EP1949904A2 Cell therapy for chronic stroke |
| 07/30/2008 | EP1949068A2 Method for preparing a sample |
| 07/30/2008 | EP1948800A1 Antiviral resistance mutants and applications thereof |
| 07/30/2008 | EP1948788A1 Method of expanding double negative t cells |
| 07/30/2008 | EP1948786A1 Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same |
| 07/30/2008 | EP1948676A1 Bioactive substance-blood protein conjugate and stabilization of a bioactive substance using the same |
| 07/30/2008 | EP1948218A2 Osteogenic device for inducing bone formation in clinical contexts |
| 07/30/2008 | EP1948206A2 Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis |
| 07/30/2008 | EP1794285A4 Methods and kits for isolating sperm cells |
| 07/30/2008 | EP1565547B1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 07/30/2008 | EP1480646B1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident |
| 07/30/2008 | EP1144600B1 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 07/30/2008 | EP0994728B1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 07/30/2008 | EP0862616B1 Reconstituted mineralized cartilage tissue |
| 07/30/2008 | CN101233231A Anti-obesity agent and anti-obesity food |
| 07/30/2008 | CN101232894A Anticancer agent to be combined with telomelysin |
| 07/30/2008 | CN101232893A Pharmaceutical composition for the treatment of nerve damage comprising blood plasma or serum |
| 07/30/2008 | CN101232867A Cosmetic and/or dermatological composition for prevention and/or treatment of sensitive or dry skin |
| 07/30/2008 | CN101230375A Jellyfish original glycoprotein having fatigue resistant activity and preparation technique thereof |
| 07/30/2008 | CN101230331A Use of baicalin in promoting vitro directional differentiation of mesenchymal stem cells and method thereof |
| 07/30/2008 | CN101230096A Peptide derived from hepatitis C virus |
| 07/30/2008 | CN101230012A Extractive separation method of cicadae flower immunological suppression active effective part ISP extracts |
| 07/30/2008 | CN101229370A Autologous T-cell vaccines against multiple sclerosis |